GILD
Gilead Sciences, Inc.
NMS
$127.57
-3.53
(-2.69%)
Pullback · -1.49σ
Valuation
Market cap
$158.4B
P/E (ttm)
17.4
Forward P/E
13.3
Beta (5y)
0.33
Shares out
1,241.6M
Div yield
257.00%
Profitability & returns
ROE
43.4%
Net margin
31.0%
FCF margin
26.7%
Debt / equity
0.95
Trading information
Last price
$127.57
Day range
$127.57 – $127.57
52-wk range
$116.88 – $157.29
Avg volume
6.1M
RSI (2)
6.3
TAO zone
Pullback
Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NMS
Next earnings
2026-08-06
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary bi…